Literature DB >> 9093318

Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.

S Nadarajah1, B Krafchik, C Roifman, C Horgan-Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9093318     DOI： 10.1542/peds.99.4.630

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  4 in total

Review 1.  Cardiac manifestation of the hypereosinophilic syndrome: new insights.

Authors:  T Kleinfeldt; C A Nienaber; S Kische; I Akin; R G Turan; T Körber; H Schneider; H Ince
Journal:  Clin Res Cardiol       Date:  2010-03-24       Impact factor: 5.460

2.  NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation.

Authors:  Hans Häcker; Liying Chi; Jerold E Rehg; Vanessa Redecke
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

3.  [Hypereosinophilic dermatitis. An overlooked diagnosis?].

Authors:  N Kemmler; W K Peitsch; E Glorer; S Goerdt
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

4.  Successful treatment of steroid resistant hypereosinophilic syndrome with low-dose CsA.

Authors:  Yun Hwa Jung; Sang Bong Han; Young Jae Park; In Sook Woo; Baik Kee Cho; Chi Wha Han
Journal:  Blood Res       Date:  2013-12-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.